• 1. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 2. An intramolecular tryptophan-condensation approach for peptide stapling?
  Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
• 3. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 4. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948
• 5. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126

Recent Advances in the Study of 1-(4-Iodophenyl)adamantane (CAS: 98611-00-8) in Chemical Biology and Pharmaceutical Research

The compound 1-(4-Iodophenyl)adamantane (CAS: 98611-00-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential as a drug candidate. The adamantane moiety, known for its rigid and lipophilic nature, combined with the iodophenyl group, offers a versatile scaffold for further chemical modifications and biological investigations.

Recent studies have explored the synthesis and characterization of 1-(4-Iodophenyl)adamantane, highlighting its potential as a building block for more complex molecules. Researchers have utilized this compound in the development of novel inhibitors targeting various enzymes and receptors. For instance, its incorporation into small-molecule libraries has facilitated the discovery of potent modulators of neurodegenerative disease-related proteins. The iodine atom in the para position of the phenyl ring provides a convenient handle for further functionalization via cross-coupling reactions, making it a valuable intermediate in medicinal chemistry.

In terms of biological activity, preliminary in vitro studies have demonstrated that 1-(4-Iodophenyl)adamantane exhibits promising interactions with specific protein targets. One notable study reported its affinity for the sigma-1 receptor, a protein implicated in neuroprotection and cancer. The compound's ability to modulate sigma-1 receptor activity suggests potential applications in treating neurological disorders and certain types of cancer. Additionally, its lipophilic nature enhances blood-brain barrier penetration, a critical factor for central nervous system-targeted therapies.

Further investigations into the pharmacokinetic properties of 1-(4-Iodophenyl)adamantane have revealed favorable stability and metabolic profiles. Animal studies have shown that the compound maintains adequate bioavailability and exhibits minimal toxicity at therapeutic doses. These findings support its potential as a lead compound for further optimization and development. Researchers are currently exploring derivatives of this compound to improve selectivity and potency, with the aim of advancing it into preclinical trials.

The versatility of 1-(4-Iodophenyl)adamantane extends beyond its therapeutic potential. It has also been employed as a molecular probe in imaging studies, leveraging the radioactive iodine isotope for positron emission tomography (PET) imaging. This application underscores its dual utility in both drug development and diagnostic imaging, making it a valuable tool in translational research. Recent advancements in radiolabeling techniques have further enhanced its utility in this domain.

In conclusion, 1-(4-Iodophenyl)adamantane (CAS: 98611-00-8) represents a promising compound in chemical biology and pharmaceutical research. Its unique structural features, combined with its diverse biological activities and applications, position it as a valuable candidate for further investigation. Ongoing research efforts are expected to yield additional insights into its mechanisms of action and therapeutic potential, paving the way for its eventual clinical application. This brief underscores the importance of continued exploration of this compound and its derivatives in addressing unmet medical needs.

• 918826-31-0(Benzene, 1-(4-ethylcyclohexyl)-4-iodo- )
• 114834-79-6(1-(Trans-4-N-Butylcyclohexyl)-4-Iodobenzene)
• 860639-66-3(Benzene,1-iodo-4-(4-propylcyclohexyl)-)
• 111158-11-3(1-Iodo-4-(trans-4-N-propylcyclohexyl)benzene)
• 948553-77-3( )
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)